A clinical case of combined differentiated thyroid cancer and primary hyperparathyroidism: the complexity of topical differential diagnosis
https://doi.org/10.14341/probl10107
Abstract
In recent years, the understanding of the epidemiology, symptoms and strategies for managing patients with hyperparathyroidism has changed significantly. The most common cases in clinical practice are of sporadic primary hyperparathyroidism, which today ranks third in prevalence among endocrine diseases (the frequency of occurrence in the adult population is, on average, 1–2%). In primary hyperparathyroidism, solitary parathyroid adenoma is detected in up to 85% of all cases. The only treatment is radical surgical removal of pathologically altered parathyroid tissue. Early diagnosis and treatment of hyperparathyroidism makes it possible to avoid severe lesions of the skeletal bones and visceral organs. A diagnostically challenging clinical case of a combined onco-endocrine pathology in a 70-year-old patient is presented. The main difficulties in the initial diagnosis were associated with the absence of pathognomonic symptoms of the disease, which was often completely asymptomatic. The most urgent problem appears to be the topical diagnosis of pathologically altered parathyroid glands. Therefore, there is a need to develop an algorithm for the combining and sequential use of existing medical imaging methods.
Keywords
About the Authors
Konstantin Yu. SlashchukRussian Federation
MD
Mikhail V. Degtyarev
Russian Federation
MD
Sergey S. Serzhenko
Russian Federation
MD
Pavel O. Rumyantsev
Russian Federation
MD, PhD
Marina S. Sheremeta
Russian Federation
MD, PhD
Valentina S. Yasuchenia
Russian Federation
MD
Alexey A. Trukhin
Russian Federation
Yaroslav I. Sirota
Russian Federation
Olga D. Baranova
Russian Federation
MD
Petr A. Nikiforovich
Russian Federation
MD
References
1. Mackenzie-Feder J, Sirrs S, Anderson D, et al. Primary hyperparathyroidism: an overview. Int J Endocrinol. 2011;2011:251410. doi: https://doi.org/10.1155/2011/251410
2. Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018;391(10116):168-178. doi: https://doi.org/10.1016/s0140-6736(17)31430-7
3. Clarke BL. Epidemiology of primary hyperparathyroidism. J Clin Densitom. 2013;16(1):8-13. doi: https://doi.org/10.1016/j.jocd.2012.11.009
4. Griebeler ML, Kearns AE, Ryu E, et al. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2015;73:1-7. doi: https://doi.org/10.1016/j.bone.2014.12.003
5. Newey PJ, Nesbit MA, Rimmer AJ, et al. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas. J Clin Endocrinol Metab. 2012;97(10):E1995-2005. doi: https://doi.org/10.1210/jc.2012-2303
6. Yu W, McPherson JR, Stevenson M, et al. Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J Clin Endocrinol Metab. 2015;100(2):E360-364. doi: https://doi.org/10.1210/jc.2014-3238
7. Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1-19. doi: https://doi.org/10.1007/s00198-016-3716-2
8. Kunstman JW, Kirsch JD, Mahajan A, Udelsman R. Clinical review: Parathyroid localization and implications for clinical management. J Clin Endocrinol Metab. 2013;98(3):902-912. doi: https://doi.org/10.1210/jc.2012-3168
9. Cusano NE, Bilezikian JP. Diagnosis and management of primary hyperparathyroidism. J Clin Outcomes Manag. 2013;(20):181-192.
10. LiVolsi VA, Montone KT, Baloch ZN. Parathyroid: The Pathology of Hyperparathyroidism. Surg Pathol Clin. 2014;7(4):515-531. doi: https://doi.org/10.1016/j.path.2014.08.004
11. Biersack H-J, Heiden U. Parathyroid Imaging. In: Bucerius J, Ahmadzadehfar H, Biersack H-J, editors. 99mTc-Sestamibi. Clinical Applications. Berlin–Heidelberg: Springer-Verlag; 2012. p. 31-63. doi: https://doi.org/10.1007/978-3-642-04233-1_4
12. Cheung K, Wang TS, Farrokhyar F, et al. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012;19(2):577-583. doi: https://doi.org/10.1245/s10434-011-1870-5
13. Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol. 2010;65(4):278-287. doi: https://doi.org/10.1016/j.crad.2009.12.005
14. Silva BC, Cusano NE, Bilezikian JP. Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(5):593-607. doi: https://doi.org/10.1016/j.beem.2018.09.004
15. Gomes EMS, Nunes RC, Lacativa PGS, et al. Ectopic and extranumerary parathyroid glands location in patients with hyperparathyroidism secondary to end stage renal disease. Acta Cir Bras. 2007;22(2):105-109. doi: https://doi.org/10.1590/s0102-86502007000200005
16. England RJ, Mehanna H. Surgery for Primary Hyperparathyroidism. 2014:253-258. doi: https://doi.org/10.1007/978-1-4471-2146-6_33
17. Delorme S, Zechmann C, Haberkorn U. (2013). Imaging diagnostics of hyperparathyroidism. Der Radiologe. 2013;53(3):261-276.
18. Mohebati A, Shaha AR. Imaging techniques in parathyroid surgery for primary hyperparathyroidism. Am J Otolaryngol. 2012;33(4):457-468. doi: https://doi.org/10.1016/j.amjoto.2011.10.010
19. Judson BL, Shaha AR. Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism. J Nucl Med. 2008;49(11):1813-1818. doi: https://doi.org/10.2967/jnumed.107.050237
20. Tublin ME, Pryma DA, Yim JH, et al. Localization of Parathyroid Adenomas by Sonography and Technetium Tc 99m Sestamibi Single-Photon Emission Computed Tomography Before Minimally Invasive Parathyroidectomy. J Ultrasound Med. 2009;28(2):183-190. doi: https://doi.org/10.7863/jum.2009.28.2.183
21. Berber E, Parikh RT, Ballem N, et al. Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery. 2008;144(1):74-79. doi: https://doi.org/10.1016/j.surg.2008.03.019
22. Udelsman R. Approach to the patient with persistent or recurrent primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96(10):2950-2958. doi: https://doi.org/10.1210/jc.2011-1010
23. Калинин А.П., Павлов А.В., Александров Ю.К. и др. Методы визуализации околощитовидных желез и паратиреоидная хирургия: Руководство для врачей. / Под ред. А.П. Калинина. – М.: Издательский дом Видар-М; 2010. [Kalinin AP, Pavlov AV, Aleksandrov YK, et al. Kalinin AP, editor. Metody vizualizatsii okoloshchitovidnykh zhelez i paratireoidnaya khirurgiya: Rukovodstvo dlya vrachey. Moscow: Vidar-M; 2010. (In Russ.)]
Supplementary files
![]() |
1. Изображения к статье | |
Subject | ||
Type | Other | |
Download
(401KB)
|
Indexing metadata ▾ |
|
2. Fig. 1. The upper row - planar scintigraphy 15 and 90 minutes after the introduction of radiopharmaceutical; bottom row - SPECT / CT after 90 min; The arrow (→) marks the zones of intense radiopharmaceutical accumulation in the projection of the right lower thyroid and the node in the lower pole of the left thyroid lobe. | |
Subject | ||
Type | Other | |
View
(351KB)
|
Indexing metadata ▾ |
|
3. Fig. 2. The diagnostic search algorithm (scheme). | |
Subject | ||
Type | Other | |
View
(254KB)
|
Indexing metadata ▾ |
Review
For citations:
Slashchuk K.Yu., Degtyarev M.V., Serzhenko S.S., Rumyantsev P.O., Sheremeta M.S., Yasuchenia V.S., Trukhin A.A., Sirota Ya.I., Baranova O.D., Nikiforovich P.A. A clinical case of combined differentiated thyroid cancer and primary hyperparathyroidism: the complexity of topical differential diagnosis. Problems of Endocrinology. 2019;65(4):243-250. https://doi.org/10.14341/probl10107

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).